 |
PRESS
RELEASES 
|
Press Release; Berlin, April 16, 2008
MOLOGEN AG explains voting rights announcements of the new major shareholders
The Berlin-based biotechnology company MOLOGEN today explained voting rights announcements granted to the company in March in accordance with Article 21 of the German Securities Trading Act. After the off-market acquisition of a large parcel of shares from Absolute Capital Management Holdings Ltd.,
The Executive Board at MOLOGEN appeared very pleased and satisfied about the intense commitment of the Deutsche Ring Group. "We are very impressed with the faith that the Deutsche Ring Group has placed in us with its long-term investment. It provides additional incentive for us to push ahead with all our might with the development of MOLOGEN and to notch up further successes", commented Dr. Schroff, Chief Executive Officer of MOLOGEN. "We expect the speculation regarding the parcel of shares held by Absolute Capital Management Holdings to finally come to an end", added Chief Financial Officer Petraß.
About MOLOGEN
MOLOGEN AG, a biopharmaceutical company based in Berlin, specializes in the research and development of innovative medicines based on DNA structures (DNA: deoxyribonucleic acid).
Its patented DNA-based technology platforms MIDGE® and dSLIM® form a universal foundation with a wide range of possible applications. Activities focus on product developments for the treatment of cancer and vaccines for serious infections in humans and animals.
MOLOGEN was founded in 1998 and was the first German biotechnology company to go public. MOLOGEN AG shares are listed in the General Standard of Deutsche Börse (ISIN DE 0006637200).
Disclaimer concerning prognoses
Certain statements in this communication contain formulations or terms referring to the future or future developments, as well as negations of such formulations or terms, or similar terminology. These are described as forward-looking statements. In addition, all information in this communication regarding planned or future results of business segments, financial classification numbers, developments of the financial situation, or other financial or statistical data contains such forward-looking statements. The company cautions prospective investors not to rely on such forward-looking statements as certain prognoses of actual future events and developments. The company is neither responsible nor liable for these forward-looking statements. It is not responsible for updating such information, which only represents the state of affairs on the day of publication.
|
|
